More importantly, we also found that icaritin exhibited powerful efficacies on primary bone marrow cells and CD138+ cells from MM patients while had not effect on proliferation of normal bone marrow cells, suggesting icaritin has low or no general cytotoxic effect on normal hematopoiesis. Here, SDC1 is linked to Miyoshi myopathy.